Comparison of Therapeutic Effect of Recombinant Tissue Plasminogen Activator by Treatment Time after Onset of Acute Ischemic Stroke
Hairong Wang(XinHua Hospital), Shuming Pan(XinHua Hospital), Sa Shen(Shanghai Jiao Tong University), Lihua Dai(Shanghai Ship and Shipping Research Institute), Feilong Wang(Fuyang Normal University), Aihua Fei(Shanghai Jiao Tong University), Ming Liu(Sun Yat-sen University), Jiafu Liu(XinHua Hospital), Miao Chen(Shanghai Jiao Tong University), Haojun Li(Capital Medical University)
Cited by 18
Related Papers
Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study
|Mediators of Inflammation|2016|228
miR‐137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells
|International Journal of Cancer|2010|167
XueBiJing Injection Versus Placebo for Critically Ill Patients With Severe Community-Acquired Pneumonia: A Randomized Controlled Trial
|Critical Care Medicine|2019|164
USF2 knockdown downregulates THBS1 to inhibit the TGF-β signaling pathway and reduce pyroptosis in sepsis-induced acute kidney injury
|Pharmacological Research|2021|139
Relationship between thyroid function and ICU mortality: a prospective observation study
|Critical Care|2012|138